Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dolby Laboratories (DLB) EBT Margin (2016 - 2025)

Dolby Laboratories' EBT Margin history spans 17 years, with the latest figure at 20.65% for Q4 2025.

  • For Q4 2025, EBT Margin fell 345.0% year-over-year to 20.65%; the TTM value through Dec 2025 reached 21.59%, down 257.0%, while the annual FY2025 figure was 22.49%, 204.0% down from the prior year.
  • EBT Margin reached 20.65% in Q4 2025 per DLB's latest filing, up from 13.57% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 33.4% in Q1 2024 to a low of 3.11% in Q3 2023.
  • Average EBT Margin over 5 years is 20.31%, with a median of 20.11% recorded in 2024.
  • Peak YoY movement for EBT Margin: crashed -1682bps in 2021, then surged 1821bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 26.0% in 2021, then rose by 15bps to 29.85% in 2022, then dropped by -14bps to 25.61% in 2023, then dropped by -6bps to 24.1% in 2024, then decreased by -14bps to 20.65% in 2025.
  • Per Business Quant, the three most recent readings for DLB's EBT Margin are 20.65% (Q4 2025), 13.57% (Q3 2025), and 17.59% (Q2 2025).